VIRALYTICS
Viralytics is an Australian biotechnology company, listed on the Australian Stock Exchange (ASX:VLA) and is quoted on the OTC market (VRACY). Focused on developing oncolytic virotherapy for the treatment of a wide range of cancers Viralytics' headquarters are in Sydney, Australia and research and operations are in Newcastle, Australia. Oncolytic virotherapy makes use of the cancer destroying capabilities of a range of benign viruses. The potential of oncolytic virotherapy is the ability to treat cancers more effectively and with minimum side-effects.
VIRALYTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2006-01-01
Address:
Sydney, New South Wales, Australia
Country:
Australia
Website Url:
http://www.viralytics.com
Total Employee:
11+
Status:
Active
Contact:
+61 2 9988 4000
Email Addresses:
[email protected]
Total Funding:
27 M USD
Technology used in webpage:
Domain Not Resolving Wordpress Plugins Fast Secure Contact Form
Similar Organizations
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Innovative Cellular Therapeutics
Innovative Cellular Therapeutics is a Shanghai-based biotechnology company engaged in research and development of cell therapy.
Founder
Stock Details
Official Site Inspections
http://www.viralytics.com
- Host name: ec2-54-163-152-178.compute-1.amazonaws.com
- IP address: 54.163.152.178
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
